Viridian Therapeutics develops biotechnology medicines for serious autoimmune and rare diseases. Its main products and services include antibody therapies and drug development programs for patients, healthcare providers, and research partners.
Viridian Therapeutics products and services overview:
Revenue: ~$0 million
Employees: 160
Headquarters: Waltham, United States (USA)
Viridian Therapeutics is one of the...
Viridian Therapeutics is a company listed under the stock ticker VRDN (US).
View the org chart displaying its 25 main executives
Create your alert
to follow the executive moves at Viridian Therapeutics.
Viridian Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.